A comprehensive review of cytochrome P450 2E1 for xenobiotic metabolism

References

• Aljomah G, Baker SS, Liu W, Kozielski R, Oluwole J, Lupu B, Baker RD, Zhu L. 2015. Induction of CYP2E1 in non-alcoholic fatty liver diseases. Exp Mol Pathol. 99:677–681.
   PubMed Web of Science ®Google Scholar
• Anandatheerthavarada HK, Addya S, Dwivedi RS, Biswas G, Mullick J, Avadhani NG. 1997. Localization of multiple forms of inducible cytochromes P450 in rat liver mitochondria: immunological characteristics and patterns of xenobiotic substrate metabolism. Arch Biochem Biophys. 339:136–150.
   PubMed Web of Science ®Google Scholar
• Ande A, Sinha N, Rao PS, McArthur CP, Ayuk L, Achu PN, Njinda A, Kumar A, Kumar S. 2015. Enhanced oxidative stress by alcohol use in HIV + patients: possible involvement of cytochrome P450 2E1 and antioxidant enzymes. AIDS Res Ther. 12:29.
   PubMed Web of Science ®Google Scholar
• Arici M, Ozhan G. 2017. The genetic profiles of CYP1A1, CYP1A2 and CYP2E1 enzymes as susceptibility factor in xenobiotic toxicity in Turkish population. Saudi Pharm J. 25:294–297.
   PubMed Web of Science ®Google Scholar
• Bansal S, Anandatheerthavarada HK, Prabu GK, Milne GL, Martin MV, Guengerich FP, Avadhani NG. 2013. Human cytochrome P450 2E1 mutations that alter mitochondrial targeting efficiency and susceptibility to ethanol-induced toxicity in cellular models. J Biol Chem. 288:12627–12644.
   PubMed Web of Science ®Google Scholar
• Barbier-Torres L, Iruzubieta P, Fernandez-Ramos D, Delgado TC, Taibo D, Guitierrez-de JV, Varela-Rey M, Azkargorta M, Navasa N, Fernandez-Tussy P, et al. 2017. The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury. Nat Commun. 8:2068.
   PubMed Web of Science ®Google Scholar
• Bellward GD, Chang T, Rodrigues B, McNeill JH, Maines S, Ryan DE, Levin W, Thomas PE. 1988. Hepatic cytochrome P-450j induction in the spontaneously diabetic BB rat. Mol Pharmacol. 33:140–143.
   PubMed Web of Science ®Google Scholar
• Bianchino G, Cittadini A, Grieco V, Traficante A, Zupa A, Improta G, Aieta M, Sgambato A. 2011. Polymorphisms of the CYP1A1, CYP2E1 and XRCC1 genes and cancer risk in a Southern Italian population: a case-control study. Anticancer Res. 31:1359–1365.
   PubMed Web of Science ®Google Scholar
• Boadas-Vaello P, Jover E, Saldana-Ruiz S, Soler-Martin C, Chabbert C, Bayona JM, Llorens J. 2009. Allylnitrile metabolism by CYP2E1 and other CYPs leads to distinct lethal and vestibulotoxic effects in the mouse. Toxicol Sci: Off J Soc Toxicol. 107:461–472.
   PubMed Web of Science ®Google Scholar
• Bogaards JJ, Bertrand M, Jackson P, Oudshoorn MJ, Weaver RJ, van Bladeren PJ, Walther B. 2000. Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica. 30:1131–1152.
   PubMed Web of Science ®Google Scholar
• Boussadia B, Ghosh C, Plaud C, Pascussi JM, de Bock F, Rousset MC, Janigro D, Marchi N. 2014. Effect of status epilepticus and antiepileptic drugs on CYP2E1 brain expression. Neuroscience. 281:124–134.
   PubMed Web of Science ®Google Scholar
• Brady JF, Ishizaki H, Fukuto JM, Lin MC, Fadel A, Gapac JM, Yang CS. 1991. Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites. Chem Res Toxicol. 4:642–647.
   PubMed Web of Science ®Google Scholar
• Brocic M, Supic G, Zeljic K, Jovic N, Kozomara R, Zagorac S, Zlatkovic M, Magic Z. 2011. Genetic polymorphisms of ADH1C and CYP2E1 and risk of oral squamous cell carcinoma. Otolaryngol Head Neck Surg. 145:586–593.
   PubMed Web of Science ®Google Scholar
• Caldwell JC, Keshava N. 2006. Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis. Environ Health Perspect. 114:1457–1463.
   PubMed Web of Science ®Google Scholar
• Caro AA, Cederbaum AI. 2005. Inhibition of CYP2E1 catalytic activity in vitro by S-adenosyl-L-methionine. Biochem Pharmacol. 69:1081–1093.
   PubMed Web of Science ®Google Scholar
• Carriere V, Goasduff T, Ratanasavanh D, Morel F, Gautier JC, Guillouzo A, Beaune P, Berthou F. 1993. Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. Chem Res Toxicol. 6:852–857.
   PubMed Web of Science ®Google Scholar
• Cederbaum AI. 2012. Alcohol metabolism. Clin Liver Dis. 16:667–685.
   PubMed Web of Science ®Google Scholar
• Cederbaum AI. 2013. Nrf2 and antioxidant defense against CYP2E1 toxicity. Sub-cellular Biochem. 67:105–130.
   PubMedGoogle Scholar
• Cederbaum AI, Lu Y, Wu D. 2009. Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol. 83:519–548.
   PubMed Web of Science ®Google Scholar
• Chang LS, Hsu YW, Lu CC, Lo MH, Hsieh KS, Li SC, Chang WC, Kuo HC. 2017. CYP2E1 gene polymorphisms related to the formation of coronary artery lesions in Kawasaki disease. Pediatr Infect Dis J. 36:1039–1043.
   PubMed Web of Science ®Google Scholar
• Chaudhuri SR, Mukherjee S, Paul RR, Haldar A, Chaudhuri K. 2013. CYP1AI and CYP2E1 gene polymorphisms may increase susceptibility to oral submucous fibrosis among betel quid chewers of eastern India. Gene. 513:268–271.
   PubMed Web of Science ®Google Scholar
• Chen W, Koenigs LL, Thompson SJ, Peter RM, Rettie AE, Trager WF, Nelson SD. 1998. Oxidation of acetaminophen to its toxic quinone imine and nontoxic catechol metabolites by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A6. Chem Res Toxicol. 11:295–301.
   PubMed Web of Science ®Google Scholar
• Chen T, Mittelstaedt RA, Beland FA, Heflich RH, Moore MM, Parsons BL. 2005. 4-Aminobiphenyl induces liver DNA adducts in both neonatal and adult mice but induces liver mutations only in neonatal mice. Int J Cancer. 117:182–187.
   PubMed Web of Science ®Google Scholar
• Chen H, Zhang X, Feng Y, Rui W, Shi Z, Wu L. 2014. Bioactive components of Glycyrrhiza uralensis mediate drug functions and properties through regulation of CYP450 enzymes. Mol Med Rep. 10:1355–1362.
   PubMed Web of Science ®Google Scholar
• Cheng J, Krausz KW, Li F, Ma X, Gonzalez FJ. 2013. CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid. Toxicol Appl Pharmacol. 266:245–253.
   PubMed Web of Science ®Google Scholar
• Choi H, Tabashidze N, Rossner P Jr, Dostal M, Pastorkova A, Kong SW, Gmuender H, Sram RJ. 2017. Altered vulnerability to asthma at various levels of ambient Benzo[a]Pyrene by CTLA4, STAT4 and CYP2E1 polymorphisms. Environ Pollut. 231:1134–1144.
   PubMed Web of Science ®Google Scholar
• Couto N, Al-Majdoub ZM, Achour B, Wright PC, Rostami-Hodjegan A, Barber J. 2019. Quantification of proteins involved in drug metabolism and disposition in the human liver using label-free global proteomics. Mol Pharm. 16:632–647.
   PubMed Web of Science ®Google Scholar
• Deka M, Bose M, Baruah B, Bose PD, Medhi S, Bose S, Saikia A, Kar P. 2010. Role of CYP2E1 gene polymorphisms association with hepatitis risk in Northeast India. World J Gastroenterol. 16:4800–4808.
   PubMed Web of Science ®Google Scholar
• Ding WX, Li M, Chen X, Ni HM, Lin CW, Gao W, Lu B, Stolz DB, Clemens DL, Yin XM. 2010. Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice. Gastroenterology. 139:1740–1752.
   PubMed Web of Science ®Google Scholar
• Donato MT, Lahoz A, Jimenez N, Perez G, Serralta A, Mir J, Castell JV, Gomez LM. 2006. Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts. Drug Metab Dispos. 34:1556–1562.
   PubMed Web of Science ®Google Scholar
• Ekstrom G, Ingelman-Sundberg M. 1989. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol. 38:1313–1319.
   PubMed Web of Science ®Google Scholar
• El Hadri L, Chanas B, Ghanayem BI. 2005. Comparative metabolism of methacrylonitrile and acrylonitrile to cyanide using cytochrome P4502E1 and microsomal epoxide hydrolase-null mice. Toxicol Appl Pharmacol. 205:116–125.
   PubMed Web of Science ®Google Scholar
• Emery MG, Jubert C, Thummel KE, Kharasch ED. 1999. Duration of cytochrome P-450 2E1 (CYP2E1) inhibition and estimation of functional CYP2E1 enzyme half-life after single-dose disulfiram administration in humans. J Pharmacol Exp Ther. 291:213–219.
   PubMed Web of Science ®Google Scholar
• Fang Z, Wu Y, Zhang N. 2017. Association between CYP2E1 genetic polymorphisms and urinary cancer risk: a meta-analysis. Oncotarget. 8:86853–86864.
   PubMedGoogle Scholar
• Ferguson CS, Tyndale RF. 2011. Cytochrome P450 enzymes in the brain: emerging evidence of biological significance. Trends Pharmacol Sci. 32:708–714.
   PubMed Web of Science ®Google Scholar
• Fontecave M, Atta M, Mulliez E. 2004. S-adenosylmethionine: nothing goes to waste. Trends Biochem Sci. 29:243–249.
   PubMed Web of Science ®Google Scholar
• French SW. 2013. The importance of CYP2E1 in the pathogenesis of alcoholic liver disease and drug toxicity and the role of the proteasome. Subcell Biochem. 67:145–164.
   PubMedGoogle Scholar
• Gan J, Skipper PL, Tannenbaum SR. 2001. Oxidation of 2,6-dimethylaniline by recombinant human cytochrome P450s and human liver microsomes. Chem Res Toxicol. 14:672–677.
   PubMed Web of Science ®Google Scholar
• Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT. 1999. Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA. 281:1318–1325.
   PubMed Web of Science ®Google Scholar
• Gebhardt AC, Lucas D, Menez JF, Seitz HK. 1997. Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans. Hepatology. 26:957–961.
   PubMed Web of Science ®Google Scholar
• Gill P, Bhattacharyya S, McCullough S, Letzig L, Mishra PJ, Luo C, Dweep H, James L. 2017. MicroRNA regulation of CYP 1A2, CYP3A4 and CYP2E1 expression in acetaminophen toxicity. Sci Rep. 7:12331.
   PubMed Web of Science ®Google Scholar
• Goh LP, Chong ET, Chua KH, Chuah JA, Lee PC. 2014. Significant genotype difference in the CYP2E1 PstI polymorphism of indigenous groups in Sabah, Malaysia with Asian and non-Asian populations. Asian Pac J Cancer Prev. 15:7377–7381.
   PubMedGoogle Scholar
• Gordillo-Bastidas E, Panduro A, Gordillo-Bastidas D, Zepeda-Carrillo EA, Garcia-Banuelos JJ, Munoz-Valle JF, Bastidas-Ramirez BE. 2010. Polymorphisms of alcohol metabolizing enzymes in indigenous Mexican population: unusual high frequency of CYP2E1*c2 allele. Alcohol Clin Exp Res. 34:142–149.
   PubMed Web of Science ®Google Scholar
• Groer C, Busch D, Patrzyk M, Beyer K, Busemann A, Heidecke CD, Drozdzik M, Siegmund W, Oswald S. 2014. Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics. J Pharm Biomed Anal. 100:393–401.
   PubMed Web of Science ®Google Scholar
• Groll N, Petrikat T, Vetter S, Colnot S, Weiss F, Poetz O, Joos TO, Rothbauer U, Schwarz M, Braeuning A. 2016. Coordinate regulation of Cyp2e1 by beta-catenin- and hepatocyte nuclear factor 1alpha-dependent signaling. Toxicology. 350–352:40–48.
   PubMed Web of Science ®Google Scholar
• Guaoua S, Ratbi I, Laarabi FZ, Elalaoui SC, Jaouad IC, Barkat A, Sefiani A. 2014. Distribution of allelic and genotypic frequencies of NAT2 and CYP2E1 variants in Moroccan population. BMC Genet. 15:156.
   PubMed Web of Science ®Google Scholar
• Guengerich FP. 1991. Reactions and significance of cytochrome P-450 enzymes. J Biol Chem. 266:10019–10022.
   PubMed Web of Science ®Google Scholar
• Guengerich FP. 1997. Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species. Chem-Biol Interact. 106:161–182.
   PubMed Web of Science ®Google Scholar
• Hajovsky H, Hu G, Koen Y, Sarma D, Cui W, Moore DS, Staudinger JL, Hanzlik RP. 2012. Metabolism and toxicity of thioacetamide and thioacetamide S-oxide in rat hepatocytes. Chem Res Toxicol. 25:1955–1963.
   PubMed Web of Science ®Google Scholar
• Hartman JH, Boysen G, Miller GP. 2012. CYP2E1 metabolism of styrene involves allostery. Drug Metab Dispos. 40:1976–1983.
   PubMed Web of Science ®Google Scholar
• Hartman JH, Letzig LG, Roberts DW, James LP, Fifer EK, Miller GP. 2015a. Cooperativity in CYP2E1 metabolism of acetaminophen and styrene mixtures. Biochem Pharmacol. 97:341–349.
   PubMed Web of Science ®Google Scholar
• Hartman JH, Martin HC, Caro AA, Pearce AR, Miller GP. 2015b. Subcellular localization of rat CYP2E1 impacts metabolic efficiency toward common substrates. Toxicology. 338:47–58.
   PubMed Web of Science ®Google Scholar
• Hartman JH, Miller GP, Meyer JN. 2017. Toxicological implications of mitochondrial localization of CYP2E1. Toxicol Res. 6:273–289.
   Web of Science ®Google Scholar
• Hayashi S, Watanabe J, Kawajiri K. 1991. Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem. 110:559–565.
   PubMed Web of Science ®Google Scholar
• Higuchi R, Fukami T, Nakajima M, Yokoi T. 2013. Prilocaine- and lidocaine-induced methemoglobinemia is caused by human carboxylesterase-, CYP2E1-, and CYP3A4-mediated metabolic activation. Drug Metab Dispos. 41:1220–1230.
   PubMed Web of Science ®Google Scholar
• Hinson JA, Roberts DW, James LP. 2010. Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol. 369–405.
   PubMedGoogle Scholar
• Hu Y, Hakkola J, Oscarson M, Ingelman-Sundberg M. 1999. Structural and functional characterization of the 5'-flanking region of the rat and human cytochrome P450 2E1 genes: identification of a polymorphic repeat in the human gene. Biochem Biophys Res Commun. 263:286–293.
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M, Johansson I. 1984. Mechanisms of hydroxyl radical formation and ethanol oxidation by ethanol-inducible and other forms of rabbit liver microsomal cytochromes P-450. J Biol Chem. 259:6447–6458.
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M, Johansson I, Yin H, Terelius Y, Eliasson E, Clot P, Albano E. 1993. Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. Alcohol. 10:447–452.
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M, Ronis MJ, Lindros KO, Eliasson E, Zhukov A. 1994. Ethanol-inducible cytochrome P4502E1: regulation, enzymology and molecular biology. Alcohol Alcoholism (Oxford, Oxfordshire) Supplement. 2:131–139.
   Google Scholar
• Inoue K, Yamazaki H, Shimada T. 2000. Characterization of liver microsomal 7-ethoxycoumarin O-deethylation and chlorzoxazone 6-hydroxylation activities in Japanese and Caucasian subjects genotyped for CYP2E1 gene. Arch Toxicol. 74:372–378.
   PubMed Web of Science ®Google Scholar
• Ioannides C. 1996. Cytochromes P450: metabolic and toxicological aspects. Boca Rotan (FL): CRC Press.
   Google Scholar
• Ishizaki H, Brady JF, Ning SM, Yang CS. 1990. Effect of phenethyl isothiocyanate on microsomal N-nitrosodimethylamine metabolism and other monooxygenase activities. Xenobiotica; Fate Foreign Compounds Biol Syst. 20:255–264.
   PubMed Web of Science ®Google Scholar
• Jamwal R, Barlock BJ, Adusumalli S, Ogasawara K, Simons BL, Akhlaghi F. 2017. Multiplex and label-free relative quantification approach for studying protein abundance of drug metabolizing enzymes in human liver microsomes using SWATH-MS. J Proteome Res. 16:4134–4143.
   PubMed Web of Science ®Google Scholar
• Jiang S, Vozmediano V. 2019. Acetaminophen protein adducts in hospitalized children receiving multiple doses of acetaminophen. J Clin Pharmacol.
   Web of Science ®Google Scholar
• Jin M, Ande A, Kumar A, Kumar S. 2013. Regulation of cytochrome P450 2e1 expression by ethanol: role of oxidative stress-mediated pkc/jnk/sp1 pathway. Cell Death Dis. 4:e554.
   PubMed Web of Science ®Google Scholar
• Johansson I, Ingelman-Sundberg M. 1985. Carbon tetrachloride-induced lipid peroxidation dependent on an ethanol-inducible form of rabbit liver microsomal cytochrome P-450. FEBS Lett. 183:265–269.
   PubMed Web of Science ®Google Scholar
• Johnsrud EK, Koukouritaki SB, Divakaran K, Brunengraber LL, Hines RN, McCarver DG. 2003. Human hepatic CYP2E1 expression during development. J Pharmacol Exp Ther. 307:402–407.
   PubMed Web of Science ®Google Scholar
• Kakino K, Kiyohara C, Horiuchi T, Nakanishi Y. 2016. CYP2E1 rs2031920, COMT rs4680 polymorphisms, cigarette smoking, alcohol use and lung cancer risk in a Japanese population. Asian Pac J Cancer Prev. 17:4063–4070.
   PubMedGoogle Scholar
• Karmakar S, Banik NL, Patel SJ, Ray SK. 2007. Garlic compounds induced calpain and intrinsic caspase cascade for apoptosis in human malignant neuroblastoma SH-SY5Y cells. Apoptosis: Int J Programmed Cell Death. 12:671–684.
   PubMed Web of Science ®Google Scholar
• Kathirvel E, Chen P, Morgan K, French SW, Morgan TR. 2010. Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mouse model of non-alcoholic fatty liver. J Gastroenterol Hepatol. 25:1136–1143.
   PubMed Web of Science ®Google Scholar
• Kayaalti Z, Soylemezoglu T. 2010. Distribution of ADH1B, ALDH2, CYP2E1 *6, and CYP2E1 *7B genotypes in Turkish population. Alcohol. 44:415–423.
   PubMed Web of Science ®Google Scholar
• Khan RA, Khan MR, Sahreen S. 2012. CCl4-induced hepatotoxicity: protective effect of rutin on p53, CYP2E1 and the antioxidative status in rat. BMC Complement Altern Med. 12:178.
   PubMed Web of Science ®Google Scholar
• Khemawoot P, Yokogawa K, Shimada T, Miyamoto K. 2007. Obesity-induced increase of CYP2E1 activity and its effect on disposition kinetics of chlorzoxazone in Zucker rats. Biochem Pharmacol. 73:155–162.
   PubMed Web of Science ®Google Scholar
• Krasniak AE, Knipp GT, Svensson CK, Liu W. 2014. Pharmacogenomics of acetaminophen in pediatric populations: a moving target. Front Genet. 5:314.
   PubMed Web of Science ®Google Scholar
• Kraus D, Rokitta D, Fuhr U, Tomalik-Scharte D. 2013. The role of human cytochrome P450 enzymes in metabolism of acrylamide in vitro. Toxicol Mech Methods. 23:346–351.
   PubMed Web of Science ®Google Scholar
• Krishnakumar D, Gurusamy U, Dhandapani K, Surendiran A, Baghel R, Kukreti R, Gangadhar R, Prayaga U, Manjunath S, Adithan C. 2012. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population. Fundam Clin Pharmacol. 26:295–306.
   PubMed Web of Science ®Google Scholar
• Kumar S, Jin M, Ande A, Sinha N, Silverstein PS, Kumar A. 2012. Alcohol consumption effect on antiretroviral therapy and HIV-1 pathogenesis: role of cytochrome P450 isozymes. Expert Opin Drug Metab Toxicol. 8:1363–1375.
   PubMed Web of Science ®Google Scholar
• Kumar S, Sinha N, Gerth KA, Rahman MA, Yallapu MM, Midde NM. 2017. Specific packaging and circulation of cytochromes P450, especially 2E1 isozyme, in human plasma exosomes and their implications in cellular communications. Biochem Biophys Res Commun. 491:675–680.
   PubMed Web of Science ®Google Scholar
• Laethem RM, Balazy M, Falck JR, Laethem CL, Koop DR. 1993. Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1. J Biol Chem. 268:12912–12918.
   PubMed Web of Science ®Google Scholar
• Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, Reisch JS, Schiodt FV, Ostapowicz G, Shakil AO. 2005. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 42:1364–1372.
   PubMed Web of Science ®Google Scholar
• Lash LH, Fisher JW, Lipscomb JC, Parker JC. 2000. Metabolism of trichloroethylene. Environ Health Perspect. 108:177–200.
   PubMed Web of Science ®Google Scholar
• Lau AH. 1999. Apoptosis induced by cisplatin nephrotoxic injury. Kidney Int. 56:1295–1298.
   PubMed Web of Science ®Google Scholar
• Lee SS, Buters JT, Pineau T, Fernandez-Salguero P, Gonzalez FJ. 1996. Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem. 271:12063–12067.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang EJ, Chen L, Stein AP, Reuhl KR, Yang CS. 1997. Effects of phenethyl isothiocyanate on acetaminophen metabolism and hepatotoxicity in mice. Toxicol Appl Pharmacol. 144:306–314.
   PubMed Web of Science ®Google Scholar
• Lieber CS. 1997. Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev. 77:517–544.
   PubMed Web of Science ®Google Scholar
• Liu W, Zhou L, Wang H, Zheng B, Wu D, Yang X, Liu J. 2014. CYP2E1 gene rs6413420 polymorphism was first found in the Bouyei ethnic group of China. Int J Clin Exp Med. 7:3612–3620.
   PubMed Web of Science ®Google Scholar
• Lu Y, Cederbaum AI. 2006. Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1. Toxicol Sci. 89:515–523.
   PubMed Web of Science ®Google Scholar
• Lu Y, Cederbaum AI. 2015. Autophagy protects against CYP2E1/chronic ethanol-induced hepatotoxicity. Biomolecules. 5:2659–2674.
   PubMed Web of Science ®Google Scholar
• Lu Y, Cederbaum AI. 2018. Cytochrome P450s and alcoholic liver disease. CPD. 24:1502–1517.
   Web of Science ®Google Scholar
• Madias NE, Harrington JT. 1978. Platinum nephrotoxicity. Am J Med. 65:307–314.
   PubMed Web of Science ®Google Scholar
• Martinez-Gil N, Flores-Bellver M, Atienzar-Aroca S, Lopez-Malo D, Urdaneta AC, Sancho-Pelluz J, Peris-Martinez C, Bonet-Ponce L, Romero FJ, Barcia JM. 2015. CYP2E1 in the human retinal pigment epithelium: expression, activity, and induction by ethanol. Invest Ophthalmol Vis Sci. 56:6855–6863.
   PubMed Web of Science ®Google Scholar
• Matsumoto H, Fukui Y. 2002. Pharmacokinetics of ethanol: a review of the methodology. Addict Biol. 7:5–14.
   PubMed Web of Science ®Google Scholar
• McGill MR, Jaeschke H. 2013. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res. 30:2174–2187.
   PubMed Web of Science ®Google Scholar
• Molina-Ortiz D, Camacho-Carranza R, Gonzalez-Zamora JF, Shalkow-Kalincovstein J, Cardenas CR, Nosti-Palacios R, Vences MA. 2014. Differential expression of cytochrome P450 enzymes in normal and tumor tissues from childhood rhabdomyosarcoma. PLoS One. 9:e93261.
   PubMed Web of Science ®Google Scholar
• Monostory K, Hazai E, Vereczkey L. 2004. Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors. Chem-Biol Interact. 147:331–340.
   PubMed Web of Science ®Google Scholar
• Neafsey P, Ginsberg G, Hattis D, Johns DO, Guyton KZ, Sonawane B. 2009. Genetic polymorphism in CYP2E1: population distribution of CYP2E1 activity. J Toxicol Environ Health *Part B Crit Rev. 12:362–388.
   PubMed Web of Science ®Google Scholar
• Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, et al. 1996. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics. 6:1–42.
   PubMedGoogle Scholar
• Nelson SD, Mitchell JR, Timbrell JA, Snodgrass WR, Corcoran GB 3rd. 1976. Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat. Science. 193:901–903.
   PubMed Web of Science ®Google Scholar
• Neuhaus T, Ko YD, Lorenzen K, Fronhoffs S, Harth V, Brode P, Vetter H, Bolt HM, Pesch B, Bruning T. 2004. Association of cytochrome P450 2E1 polymorphisms and head and neck squamous cell cancer. Toxicol Lett. 151:273–282.
   PubMed Web of Science ®Google Scholar
• Park HJ, Choi YJ, Kim JW, Chun HS, Im I, Yoon S, Han YM, Song CW, Kim H. 2015. Differences in the epigenetic regulation of cytochrome P450 genes between human embryonic stem cell-derived hepatocytes and primary hepatocytes. PLoS One. 10:e0132992.
   PubMed Web of Science ®Google Scholar
• Park WJ, Kim SY, Kim YR, Park JW. 2016. Bortezomib alleviates drug-induced liver injury by regulating CYP2E1 gene transcription. Int J Mol Med. 37:613–622.
   PubMed Web of Science ®Google Scholar
• Park KS, Sohn DH, Veech RL, Song BJ. 1993. Translational activation of ethanol-inducible cytochrome P450 (CYP2E1) by isoniazid. Eur J Pharmacol. 248:7–14.
   PubMed Web of Science ®Google Scholar
• Penaloza CG, Estevez B, Han DM, Norouzi M, Lockshin RA, Zakeri Z. 2014. Sex-dependent regulation of cytochrome P450 family members Cyp1a1, Cyp2e1, and Cyp7b1 by methylation of DNA. FASEB J. 28:966–977.
   PubMed Web of Science ®Google Scholar
• Peter R, Boecker R, Beaune PH, Iwasaki M, Guengerich FP, Yang CS. 1990. Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem Res Toxicol. 3:566–573.
   PubMed Web of Science ®Google Scholar
• Rahman MA, Gong Y, Kumar S. 2018. In vitro evaluation of structural analogs of diallyl sulfide as novel CYP2E1 inhibitors for their protective effect against xenobiotic-induced toxicity and HIV replication. Toxicol Lett. 292:31–38.
   PubMed Web of Science ®Google Scholar
• Rahman MA, Midde NM, Wu X, Li W, Kumar S. 2017. Kinetic characterizations of diallyl sulfide analogs for their novel role as CYP2E1 enzyme inhibitors. Pharmacol Res Perspect. 5:e00362.
   PubMed Web of Science ®Google Scholar
• Rahman MA, Kodidela S, Sinha N, Haque S, Shukla PK, Rao R, Kumar S. 2019. Plasma exosomes exacerbate alcohol- and acetaminophen-induced toxicity via CYP2E1 pathway. Sci Rep. 9:6571.
   PubMed Web of Science ®Google Scholar
• Rao PS, Midde NM, Miller DD, Chauhan S, Kumar A, Kumar S. 2015. Diallyl sulfide: potential use in novel therapeutic interventions in alcohol, drugs, and disease mediated cellular toxicity by targeting cytochrome P450 2E1. CDM. 16:486–503.
   Web of Science ®Google Scholar
• Raucy JL, Kraner JC, Lasker JM. 1993. Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit Rev Toxicol. 23:1–20.
   PubMed Web of Science ®Google Scholar
• Raza H, Prabu SK, Robin MA, Avadhani NG. 2004. Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin-induced diabetic rats: tissue-specific variations and roles in oxidative stress. Diabetes. 53:185–194.
   PubMed Web of Science ®Google Scholar
• Ronis MJ, Huang J, Crouch J, Mercado C, Irby D, Valentine CR, Lumpkin CK, Ingelman-Sundberg M, Badger TM. 1993. Cytochrome P450 CYP 2E1 induction during chronic alcohol exposure occurs by a two-step mechanism associated with blood alcohol concentrations in rats. J Pharmacol Exp Therapeutics. 264:944–950.
   PubMed Web of Science ®Google Scholar
• Ronis MJ, Johansson I, Hultenby K, Lagercrantz J, Glaumann H, Ingelman-Sundberg M. 1991. Acetone-regulated synthesis and degradation of cytochrome P450E1 and cytochrome P4502B1 in rat liver [corrected]. Eur J Biochem. 198:383–389.
   PubMedGoogle Scholar
• Saldana-Ruiz S, Soler-Martin C, Llorens J. 2012. Role of CYP2E1-mediated metabolism in the acute and vestibular toxicities of nineteen nitriles in the mouse. Toxicol Lett. 208:125–132.
   PubMed Web of Science ®Google Scholar
• Shahriary GM, Galehdari H, Jalali A, Zanganeh F, Alavi SM, Aghanoori MR. 2012. CYP2E1*5B, CYP2E1*6, CYP2E1*7B, CYP2E1*2, and CYP2E1*3 allele frequencies in Iranian populations. Asian Pac J Cancer Prev. 13:6505–6510.
   PubMed Web of Science ®Google Scholar
• Sharer JE, Shipley LA, Vandenbranden MR, Binkley SN, Wrighton SA. 1995. Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. Drug Metabol Disposition. 23:1231–1241.
   PubMed Web of Science ®Google Scholar
• Shimada T, Tsumura F, Yamazaki H. 1999. Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes. Drug Metabol Disposition. 27:1274–1280.
   PubMed Web of Science ®Google Scholar
• Simi A, Ingelman-Sundberg M. 1999. Post-translational inhibition of cytochrome P-450 2E1 expression by chlomethiazole in Fao hepatoma cells. J Pharmacol Exp Therapeutics. 289:847–852.
   PubMed Web of Science ®Google Scholar
• Spatzenegger M, Liu H, Wang Q, Debarber A, Koop DR, Halpert JR. 2003. Analysis of differential substrate selectivities of CYP2B6 and CYP2E1 by site-directed mutagenesis and molecular modeling. J Pharmacol Exp Ther. 304:477–487.
   PubMed Web of Science ®Google Scholar
• Su XL, Bin B, Cui HW, Ran MR. 2011. Cytochrome P450 2E1 RsaI/PstI and DraI polymorphisms are risk factors for lung cancer in Mongolian and Han Population in Inner Mongolia. Chin J Cancer Res. 23:107–111.
   PubMed Web of Science ®Google Scholar
• Swaminathan K, Kumar SM, Clemens DL, Dey A. 2013. Inhibition of CYP2E1 leads to decreased advanced glycated end product formation in high glucose treated ADH and CYP2E1 over-expressing VL-17A cells. Biochim Biophys Acta. 1830:4407–4416.
   PubMed Web of Science ®Google Scholar
• Teixeira RL, Morato RG, Cabello PH, Muniz LM, Moreira Ada S, Kritski AL, Mello FC, Suffys PN, Miranda AB, Santos AR. 2011. Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients. Mem Inst Oswaldo Cruz. 106:716–724.
   PubMed Web of Science ®Google Scholar
• Terelius Y, Ingelman-Sundberg M. 1986. Metabolism of n-pentane by ethanol-inducible cytochrome P-450 in liver microsomes and reconstituted membranes. Eur J Biochem. 161:303–308.
   PubMedGoogle Scholar
• Trafalis DT, Panteli ES, Grivas A, Tsigris C, Karamanakos PN. 2010. CYP2E1 and risk of chemically mediated cancers. Expert Opin Drug Metab Toxicol. 6:307–319.
   PubMed Web of Science ®Google Scholar
• Uchimoto T, Itoga S, Nezu M, Sunaga M, Tomonaga T, Nomura F. 2007. Role of the genetic polymorphisms in the 5'-flanking region for transcriptional regulation of the human CYP2E1 gene. Alcohol Clin Exp Res. 31:S36–S42.
   PubMed Web of Science ®Google Scholar
• Ueshima Y, Tsutsumi M, Takase S, Matsuda Y, Kawahara H. 1996. Acetaminophen metabolism in patients with different cytochrome P-4502E1 genotypes. Alcoholism Clin Exp Res. 20:25a–28a.
   PubMed Web of Science ®Google Scholar
• Ulusoy G, Arinc E, Adali O. 2007. Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population. Arch Toxicol. 81:711–718.
   PubMed Web of Science ®Google Scholar
• Vieira I, Sonnier M, Cresteil T. 1996. Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period. Eur J Biochem. 238:476–483.
   PubMedGoogle Scholar
• Wallace MC, Hamesch K, Lunova M, Kim Y, Weiskirchen R, Strnad P, Friedman SL. 2015. Standard operating procedures in experimental liver research: thioacetamide model in mice and rats. Lab Anim. 49:21–29.
   PubMed Web of Science ®Google Scholar
• Wang S, Bott D, Tung A, Sugamori KS, Grant DM. 2015a. Relative contributions of CYP1A2 and CYP2E1 to the bioactivation and clearance of 4-aminobiphenyl in adult mice. Drug Metab Dispos. 43:916–921.
   PubMed Web of Science ®Google Scholar
• Wang J, Hu Y, Nekvindova J, Ingelman-Sundberg M, Neve EP. 2010. IL-4-mediated transcriptional regulation of human CYP2E1 by two independent signaling pathways. Biochem Pharmacol. 80:1592–1600.
   PubMed Web of Science ®Google Scholar
• Wang T, Shankar K, Ronis MJ, Mehendale HM. 2000. Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1. J Pharmacol Exp Therapeutics. 294:473–479.
   PubMed Web of Science ®Google Scholar
• Wang S, Sugamori KS, Tung A, McPherson JP, Grant DM. 2015b. N-hydroxylation of 4-aminobiphenyl by CYP2E1 produces oxidative stress in a mouse model of chemically induced liver cancer. Toxicol Sci. 144:393–405.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yu D, Tolleson WH, Yu L-R, Green B, Zeng L, Chen Y, Chen S, Ren Z, Guo L, et al. 2017. A systematic evaluation of microRNAs in regulating human hepatic CYP2E1. Biochem Pharmacol. 138:174–184.
   PubMed Web of Science ®Google Scholar
• Wauthier V, Schenten V, Verbeeck RK, Calderon PB. 2006. Ageing is associated with increased expression but decreased activity of CYP2E1 in male Wistar rats. Life Sci. 79:1913–1920.
   PubMed Web of Science ®Google Scholar
• Weber LW, Boll M, Stampfl A. 2003. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol. 33:105–136.
   PubMed Web of Science ®Google Scholar
• Wenker MA, Kezic S, Monster AC, de Wolff FA. 2001. Metabolic capacity and interindividual variation in toxicokinetics of styrene in volunteers. Hum Exp Toxicol. 20:221–228.
   PubMed Web of Science ®Google Scholar
• Wilby MJ, Hutchinson PJ. 2004. The pharmacology of chlormethiazole: a potential neuroprotective agent? CNS Drug Rev. 10:281–294.
   PubMedGoogle Scholar
• Woodcroft KJ, Hafner MS, Novak RF. 2002. Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression. Hepatology. 35:263–273.
   PubMed Web of Science ®Google Scholar
• Wu YS, Salmela KS, Lieber CS. 1998. Microsomal acetaldehyde oxidation is negligible in the presence of ethanol. Alcohol Clin Exp Res. 22:1165–1169.
   PubMed Web of Science ®Google Scholar
• Xu L, Yang M, Zhao T, Jin H, Xu Z, Li M, Chen H. 2014. The polymorphism of CYP2E1 Rsa I/Pst I gene and susceptibility to respiratory system cancer: a systematic review and meta-analysis of 34 studies. Medicine. 93:e178.
   PubMed Web of Science ®Google Scholar
• Yamamura Y, Koyama N, Umehara K. 2015. Comprehensive kinetic analysis and influence of reaction components for chlorzoxazone 6-hydroxylation in human liver microsomes with CYP antibodies. Xenobiotica. 45:353–360.
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Nakano M, Gillam EM, Bell LC, Guengerich FP, Shimada T. 1996. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes. Biochem Pharmacol. 52:301–309.
   PubMed Web of Science ®Google Scholar
• Yamazoe Y, Ito K, Yoshinari K. 2011. Construction of a CYP2E1-template system for prediction of the metabolism on both site and preference order. Drug Metab Rev. 43:409–439.
   PubMed Web of Science ®Google Scholar
• Yang CS, Chhabra SK, Hong JY, Smith TJ. 2001. Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide (DAS) and related compounds from garlic. J Nutr. 131:1041S–1045S.
   PubMed Web of Science ®Google Scholar
• Yin X, Xiong W, Wang Y, Tang W, Xi W, Qian S, Guo Y. 2018. Association of CYP2E1 gene polymorphisms with bladder cancer risk: a systematic review and meta-analysis. Medicine. 97:e11910.
   PubMed Web of Science ®Google Scholar
• Yoon M, Madden MC, Barton HA. 2007. Extrahepatic metabolism by CYP2E1 in PBPK modeling of lipophilic volatile organic chemicals: impacts on metabolic parameter estimation and prediction of dose metrics. J Toxicol Environ Health Part A. 70:1527–1541.
   PubMed Web of Science ®Google Scholar
• Zanger UM, Schwab M. 2013. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 138:103–141.
   PubMed Web of Science ®Google Scholar
• Zhang T, Xiang CD, Gale D, Carreiro S, Wu EY, Zhang EY. 2008. Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: implications for ocular drug disposition. Drug Metab Dispos. 36:1300–1307.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Dong G, Luo H, Cao J, Wang C, Wu J, Feng YQ, Yue J. 2012. Induction of brain CYP2E1 by chronic ethanol treatment and related oxidative stress in hippocampus, cerebellum, and brainstem. Toxicology. 302:275–284.
   PubMed Web of Science ®Google Scholar
• Zhong XB, Leeder JS. 2013. Epigenetic regulation of ADME-related genes: focus on drug metabolism and transport. Drug Metab Dispos. 41:1721–1724.
   PubMed Web of Science ®Google Scholar
• Zhong S, Han W, Hou C, Liu J, Wu L, Liu M, Liang Z, Lin H, Zhou L, Liu S, et al. 2017. Relation of transcriptional factors to the expression and activity of cytochrome P450 and UDP-glucuronosyltransferases 1A in human liver: co-expression network analysis. Aaps J. 19:203–214.
   PubMed Web of Science ®Google Scholar
• Zimmerman HJ, Maddrey WC. 1995. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology. 22:767–773.
   PubMed Web of Science ®Google Scholar
• Zuber R, Anzenbacherova E, Anzenbacher P. 2002. Cytochromes P450 and experimental models of drug metabolism. J Cell Mol Med. 6:189–198.
   PubMed Web of Science ®Google Scholar